Skip to Main content Skip to Navigation
Journal articles

Human Glioblastoma Stem-Like Cells are More Sensitive to Allogeneic NK and T Cell-Mediated Killing Compared with Serum-Cultured Glioblastoma Cells.

Abstract : Glioblastoma multiforme (GBM) is the most dramatic primary brain cancer with a very poor prognosis because of inevitable disease recurrence. The median overall survival is less than 1 year after diagnosis. Cancer stem cells have recently been disclosed in GBM. GBM stem-like cells (GSCs) exhibit resistance to radio/chemotherapeutic treatments and are therefore considered to play an important role in disease recurrence. GSCs are thus appealing targets for new treatments for GBM patients. In this study, we show that GBM cells with stem cell characteristics are resistant to lysis mediated by resting natural killer (NK) cells because of the expression of MHC class I molecules. However, GSCs are killed by lectin-activated NK cells. Furthermore, in experiments using the therapeutic antibody CetuximAb, we show that GSCs are sensitive to antibody-mediated cytotoxicity. We confirm the sensitivity of GSC to cytotoxicity carried out by IL2-activated NK cells and tumor-specific T cells. More importantly, we show that GSCs are more sensitive to NK and T cell-mediated lysis relatively to their corresponding serum-cultured GBM cells obtained from the same initial tumor specimen. Altogether, these results demonstrate the sensitivity of GSC to immune cell cytotoxicity and, therefore, strongly suggest that GSCs are suitable target cells for immunotherapy of GBM patients.
Complete list of metadatas

https://www.hal.inserm.fr/inserm-00618443
Contributor : Hervé de Villemeur <>
Submitted on : Thursday, September 1, 2011 - 5:42:13 PM
Last modification on : Monday, June 29, 2020 - 2:18:01 PM

Links full text

Identifiers

Citation

Tony Avril, Elodie Vauléon, Abderrahmane Hamlat, Stéphan Saikali, Amandine Etcheverry, et al.. Human Glioblastoma Stem-Like Cells are More Sensitive to Allogeneic NK and T Cell-Mediated Killing Compared with Serum-Cultured Glioblastoma Cells.. Brain Pathology, Wiley, 2012, 22 (2), pp.159-74. ⟨10.1111/j.1750-3639.2011.00515.x⟩. ⟨inserm-00618443⟩

Share

Metrics

Record views

383